| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIP | Common Stock | Sale | $487,964 | -7,946 | -1.1% | $61.41 | 724,674 | 17 Jun 2024 | Held by Esjay LLC | F1, F2, F3 |
| transaction | ANIP | Common Stock | Sale | $644,481 | -10,607 | -1.5% | $60.76 | 714,067 | 18 Jun 2024 | Held by Esjay LLC | F1, F3, F4 |
| transaction | ANIP | Common Stock | Sale | $685,217 | -11,447 | -1.6% | $59.86 | 702,620 | 20 Jun 2024 | Held by Esjay LLC | F1, F3, F5 |
| holding | ANIP | Common Stock | 68,652 | 17 Jun 2024 | Direct | ||||||
| holding | ANIP | Common Stock | 5,000 | 17 Jun 2024 | Held by SS Pharma LLC | F6 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. |
| F2 | The shares were sold in multiple trades at prices ranging from $60.77 to $62.55. The price reported above reflects the weighted average sales price. |
| F3 | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| F4 | The shares were sold in multiple trades at prices ranging from $60.33 to $61.82. The price reported above reflects the weighted average sales price. |
| F5 | The shares were sold in multiple trades at prices ranging from $59.40 to $60.50. The price reported above reflects the weighted average sales price. |
| F6 | The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. |